136 related articles for article (PubMed ID: 11400114)
1. Molecular analyses of the mitotic checkpoint components hsMAD2, hBUB1 and hBUB3 in human cancer.
Hernando E; Orlow I; Liberal V; Nohales G; Benezra R; Cordon-Cardo C
Int J Cancer; 2001 Jul; 95(4):223-7. PubMed ID: 11400114
[TBL] [Abstract][Full Text] [Related]
2. Mutational inactivation of mitotic checkpoint genes, hsMAD2 and hBUB1, is rare in sporadic digestive tract cancers.
Imai Y; Shiratori Y; Kato N; Inoue T; Omata M
Jpn J Cancer Res; 1999 Aug; 90(8):837-40. PubMed ID: 10543255
[TBL] [Abstract][Full Text] [Related]
3. Mutation analysis of hBUB1, hBUBR1 and hBUB3 genes in glioblastomas.
Reis RM; Nakamura M; Masuoka J; Watanabe T; Colella S; Yonekawa Y; Kleihues P; Ohgaki H
Acta Neuropathol; 2001 Apr; 101(4):297-304. PubMed ID: 11355300
[TBL] [Abstract][Full Text] [Related]
4. Mitotic checkpoint protein hsMAD2 as a marker predicting liver metastasis of human gastric cancers.
Tanaka K; Nishioka J; Kato K; Nakamura A; Mouri T; Miki C; Kusunoki M; Nobori T
Jpn J Cancer Res; 2001 Sep; 92(9):952-8. PubMed ID: 11572763
[TBL] [Abstract][Full Text] [Related]
5. Somatic mutation of the hBUB1 mitotic checkpoint gene in primary lung cancer.
Gemma A; Seike M; Seike Y; Uematsu K; Hibino S; Kurimoto F; Yoshimura A; Shibuya M; Harris CC; Kudoh S
Genes Chromosomes Cancer; 2000 Nov; 29(3):213-8. PubMed ID: 10992296
[TBL] [Abstract][Full Text] [Related]
6. Frequent impairment of the spindle assembly checkpoint in hepatocellular carcinoma.
Saeki A; Tamura S; Ito N; Kiso S; Matsuda Y; Yabuuchi I; Kawata S; Matsuzawa Y
Cancer; 2002 Apr; 94(7):2047-54. PubMed ID: 11932908
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional abnormality of the hsMAD2 mitotic checkpoint gene is a potential link to hepatocellular carcinogenesis.
Jeong SJ; Shin HJ; Kim SJ; Ha GH; Cho BI; Baek KH; Kim CM; Lee CW
Cancer Res; 2004 Dec; 64(23):8666-73. PubMed ID: 15574775
[TBL] [Abstract][Full Text] [Related]
8. Mitotic checkpoint genes hBUB1, hBUB1B, hBUB3 and TTK in human bladder cancer, screening for mutations and loss of heterozygosity.
Olesen SH; Thykjaer T; Ørntoft TF
Carcinogenesis; 2001 May; 22(5):813-5. PubMed ID: 11323402
[TBL] [Abstract][Full Text] [Related]
9. Infrequent mutation of the hBUB1 and hBUBR1 genes in human lung cancer.
Sato M; Sekido Y; Horio Y; Takahashi M; Saito H; Minna JD; Shimokata K; Hasegawa Y
Jpn J Cancer Res; 2000 May; 91(5):504-9. PubMed ID: 10835495
[TBL] [Abstract][Full Text] [Related]
10. Mutation analysis of hBUB1, human mitotic checkpoint gene in multiple carcinomas.
Mimori K; Inoue H; Alder H; Ueo H; Tanaka Y; Mori M
Oncol Rep; 2001; 8(1):39-42. PubMed ID: 11115566
[TBL] [Abstract][Full Text] [Related]
11. Frequent mutations of human Mad2, but not Bub1, in gastric cancers cause defective mitotic spindle checkpoint.
Kim HS; Park KH; Kim SA; Wen J; Park SW; Park B; Gham CW; Hyung WJ; Noh SH; Kim HK; Song SY
Mutat Res; 2005 Oct; 578(1-2):187-201. PubMed ID: 16112690
[TBL] [Abstract][Full Text] [Related]
12. Characterization of regions in hsMAD1 needed for binding hsMAD2. A polymorphic change in an hsMAD1 leucine zipper affects MAD1-MAD2 interaction and spindle checkpoint function.
Iwanaga Y; Kasai T; Kibler K; Jeang KT
J Biol Chem; 2002 Aug; 277(34):31005-13. PubMed ID: 12042300
[TBL] [Abstract][Full Text] [Related]
13. Mitotic checkpoint genes, hsMAD2 and BubR1, in oesophageal squamous cancer cells and their association with 5-fluorouracil and cisplatin-based radiochemotherapy.
Tanaka K; Mohri Y; Ohi M; Yokoe T; Koike Y; Morimoto Y; Miki C; Tonouchi H; Kusunoki M
Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):639-46. PubMed ID: 18691855
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of the mitotic spindle assembly checkpoint genes hBUB1, hBUBR1 and hMAD2 in thyroid carcinomas with aggressive nature.
Wada N; Yoshida A; Miyagi Y; Yamamoto T; Nakayama H; Suganuma N; Matsuzu K; Masudo K; Hirakawa S; Rino Y; Masuda M; Imada T
Anticancer Res; 2008; 28(1A):139-44. PubMed ID: 18383837
[TBL] [Abstract][Full Text] [Related]
15. Genetic and epigenetic inactivation of mitotic checkpoint genes hBUB1 and hBUBR1 and their relationship to survival.
Shichiri M; Yoshinaga K; Hisatomi H; Sugihara K; Hirata Y
Cancer Res; 2002 Jan; 62(1):13-7. PubMed ID: 11782350
[TBL] [Abstract][Full Text] [Related]
16. Identification of frequent impairment of the mitotic checkpoint and molecular analysis of the mitotic checkpoint genes, hsMAD2 and p55CDC, in human lung cancers.
Takahashi T; Haruki N; Nomoto S; Masuda A; Saji S; Osada H; Takahashi T
Oncogene; 1999 Jul; 18(30):4295-300. PubMed ID: 10439037
[TBL] [Abstract][Full Text] [Related]
17. Identification of a human mitotic checkpoint gene: hsMAD2.
Li Y; Benezra R
Science; 1996 Oct; 274(5285):246-8. PubMed ID: 8824189
[TBL] [Abstract][Full Text] [Related]
18. Mutation analysis of hBUB1 in aneuploid HNSCC and lung cancer cell lines.
Yamaguchi K; Okami K; Hibi K; Wehage SL; Jen J; Sidransky D
Cancer Lett; 1999 May; 139(2):183-7. PubMed ID: 10395177
[TBL] [Abstract][Full Text] [Related]
19. Human Bub1: a putative spindle checkpoint kinase closely linked to cell proliferation.
Ouyang B; Lan Z; Meadows J; Pan H; Fukasawa K; Li W; Dai W
Cell Growth Differ; 1998 Oct; 9(10):877-85. PubMed ID: 9790499
[TBL] [Abstract][Full Text] [Related]
20. Mutation analysis of mitotic checkpoint genes (hBUB1 and hBUBR1) and microsatellite instability in adult T-cell leukemia/lymphoma.
Ohshima K; Haraoka S; Yoshioka S; Hamasaki M; Fujiki T; Suzumiya J; Kawasaki C; Kanda M; Kikuchi M
Cancer Lett; 2000 Oct; 158(2):141-50. PubMed ID: 10960763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
